Silo Pharma OTC Stock Forecast - Simple Moving Average
| SILO Stock | USD 0.37 0.01 2.78% |
The Simple Moving Average forecasted value of Silo Pharma on the next trading day is expected to be 0.37 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 0.94. Silo OTC Stock Forecast is based on your current time horizon.
As of today the value of rsi of Silo Pharma's share price is below 20 . This usually implies that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Silo Pharma based on different types of headlines from major news networks to social media. Using Silo Pharma hype-based prediction, you can estimate the value of Silo Pharma from the perspective of Silo Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Silo Pharma on the next trading day is expected to be 0.37 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 0.94. Silo Pharma after-hype prediction price | USD 0.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Silo |
Silo Pharma Additional Predictive Modules
Most predictive techniques to examine Silo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Silo using various technical indicators. When you analyze Silo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Silo Pharma Simple Moving Average Price Forecast For the 24th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Silo Pharma on the next trading day is expected to be 0.37 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0004, and the sum of the absolute errors of 0.94.Please note that although there have been many attempts to predict Silo OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Silo Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Silo Pharma OTC Stock Forecast Pattern
| Backtest Silo Pharma | Silo Pharma Price Prediction | Buy or Sell Advice |
Silo Pharma Forecasted Value
In the context of forecasting Silo Pharma's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Silo Pharma's downside and upside margins for the forecasting period are 0 and 5.00, respectively. We have considered Silo Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Silo Pharma otc stock data series using in forecasting. Note that when a statistical model is used to represent Silo Pharma otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 108.5315 |
| Bias | Arithmetic mean of the errors | 0.0052 |
| MAD | Mean absolute deviation | 0.0158 |
| MAPE | Mean absolute percentage error | 0.0379 |
| SAE | Sum of the absolute errors | 0.945 |
Predictive Modules for Silo Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Silo Pharma. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Silo Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Silo Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Silo Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Silo Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Silo Pharma Estimiated After-Hype Price Volatility
In the context of predicting Silo Pharma's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Silo Pharma's historical news coverage. Silo Pharma's after-hype downside and upside margins for the prediction period are 0.02 and 5.04, respectively. We have considered Silo Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Silo Pharma is out of control at this time. Analysis and calculation of next after-hype price of Silo Pharma is based on 3 months time horizon.
Silo Pharma OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Silo Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Silo Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Silo Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.61 | 4.63 | 0.34 | 0.05 | 3 Events / Month | 5 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.37 | 0.41 | 10.79 |
|
Silo Pharma Hype Timeline
Silo Pharma is at this time traded for 0.37. The entity has historical hype elasticity of -0.34, and average elasticity to hype of competition of 0.05. Silo is expected to increase in value after the next headline, with the price projected to jump to 0.41 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 10.79%, whereas the daily expected return is at this time at -0.61%. The volatility of related hype on Silo Pharma is about 5860.76%, with the expected price after the next announcement by competition of 0.42. The company has a current ratio of 32.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Silo Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Silo Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Silo Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Silo to invest in growth at high rates of return. When we think about Silo Pharma's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next expected press release will be in about 3 days. Check out Historical Fundamental Analysis of Silo Pharma to cross-verify your projections.Silo Pharma Related Hype Analysis
Having access to credible news sources related to Silo Pharma's direct competition is more important than ever and may enhance your ability to predict Silo Pharma's future price movements. Getting to know how Silo Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Silo Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CNSP | CNS Pharmaceuticals | 0.01 | 8 per month | 0.00 | (0.12) | 7.22 | (7.57) | 26.44 | |
| JAGX | Jaguar Animal Health | (0.14) | 8 per month | 0.00 | (0.07) | 9.71 | (16.87) | 125.57 | |
| GRI | GRI Bio | (0.02) | 3 per month | 0.00 | (0.25) | 11.88 | (12.95) | 76.91 | |
| BDRX | Biodexa Pharmaceticals | 1.55 | 9 per month | 0.00 | (0.05) | 11.45 | (16.09) | 128.35 | |
| KZIA | Kazia Therapeutics Ltd | 2.03 | 8 per month | 9.73 | 0.05 | 14.69 | (18.36) | 78.79 | |
| CANF | Can Fite Biopharma | 0.54 | 9 per month | 0.00 | (0.17) | 10.40 | (8.59) | 38.42 | |
| SNGX | Soligenix | (0.03) | 9 per month | 0.00 | (0.05) | 7.03 | (6.25) | 30.10 | |
| CMND | Clearmind Medicine Common | 0.12 | 10 per month | 0.00 | (0.32) | 11.72 | (21.84) | 56.34 | |
| INM | InMed Pharmaceuticals | 0.02 | 8 per month | 0.00 | (0.15) | 7.48 | (9.30) | 30.84 | |
| TTNP | Titan Pharmaceuticals | (3.29) | 27 per month | 5.38 | 0.03 | 9.38 | (8.08) | 30.41 |
Other Forecasting Options for Silo Pharma
For every potential investor in Silo, whether a beginner or expert, Silo Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Silo OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Silo. Basic forecasting techniques help filter out the noise by identifying Silo Pharma's price trends.Silo Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Silo Pharma otc stock to make a market-neutral strategy. Peer analysis of Silo Pharma could also be used in its relative valuation, which is a method of valuing Silo Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Silo Pharma Market Strength Events
Market strength indicators help investors to evaluate how Silo Pharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Silo Pharma shares will generate the highest return on investment. By undertsting and applying Silo Pharma otc stock market strength indicators, traders can identify Silo Pharma entry and exit signals to maximize returns.
| Accumulation Distribution | 2200.89 | |||
| Daily Balance Of Power | 0.5 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 0.37 | |||
| Day Typical Price | 0.37 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
Silo Pharma Risk Indicators
The analysis of Silo Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Silo Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting silo otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.45 | |||
| Standard Deviation | 4.62 | |||
| Variance | 21.34 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Silo Pharma
The number of cover stories for Silo Pharma depends on current market conditions and Silo Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Silo Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Silo Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Silo Pharma Short Properties
Silo Pharma's future price predictability will typically decrease when Silo Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Silo Pharma often depends not only on the future outlook of the potential Silo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Silo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.1 M | |
| Cash And Short Term Investments | 7.7 M |
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.